Payer PolicyActive
Rebreathing of Inert Gas for Measurement of Cardiac Output and Validation of Intra-Cardiac Shunt
AETNA-CPB-0714
Aetna
Effective: September 21, 2023
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Rebreathing of inert gas for measuring cardiac output, predicting survival in pulmonary hypertension, or validating intra‑cardiac shunt is considered experimental/investigational and not covered because effectiveness has not been established. It is explicitly noted as not covered for ICD‑10 codes I27.0, I27.20‑I27.29 and Q21.0‑Q21.9, and no specific CPT/HCPCS codes are assigned in this policy.
Coverage Criteria Preview
Key requirements from the full policy
"Rebreathing of inert gas for the measurement of cardiac output is considered experimental and investigational because the effectiveness has not been established."
Sign up to see full coverage criteria, indications, and limitations.